[DRUG THERAPY OF UTERINE CANCER].
D000970:Antineoplastic Agents; D001375:Azaguanine; D001774:Blood Chemical Analysis; D002374:Catalase; D004796:Clinical Enzyme Tests; D004247:DNA; D003851:Deoxyribonucleases; D005260:Female; D005634:Fructose-Bisphosphate Aldolase; D006801:Humans; D007770:L-Lactate Dehydrogenase; D008660:Metabolism; D016685:Mitomycin; D008937:Mitomycins; D009369:Neoplasms / Q000628:therapy*; D010827:Physiology; D012260:Ribonucleases; D002583:Uterine Cervical Neoplasms; D014594:Uterine Neoplasms
D000970:Antineoplastic Agents; D008937:Mitomycins; D016685:Mitomycin; D004247:DNA; D007770:L-Lactate Dehydrogenase; D002374:Catalase; D003851:Deoxyribonucleases; D012260:Ribonucleases; D005634:Fructose-Bisphosphate Aldolase; D001375:Azaguanine
ALDOLASE; ANTINEOPLASTIC AGENTS; AZAGUANINE; BLOOD CHEMICAL ANALYSIS; CATALASE; CERVIX NEOPLASMS; DEOXYRIBONUCLEASE; ENZYME TESTS; LACTATE DEHYDROGENASE; METABOLISM; MITOMYCIN; NEOPLASM THERAPY; PHYSIOLOGY; RIBONUCLEASE